Medesis Pharma S.A.
PAR: ALMDP.PA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Euronext Paris
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Jean-Claude Maurel MHB
- Employees
- 10
- Headquarters
- Montpellier, France
- IPO year
- 2021
- Market cap
- €1.8M
- Website
- https://www.medesispharma.com
Loading ALMDP…
Loading profile data…Frequently asked questions about ALMDP
What does Medesis Pharma S.A. (ALMDP.PA) do?
Medesis Pharma S.A., a clinical development stage biopharmaceutical company, engages in the development of orally administered molecule drug candidates to address unmet medical needs. Its products include NanoLithium (NP03), a clinical stage development product for the treatment of Alzheimer's disease; NanosiRNA DH for the treatment of Huntingto...
Where does ALMDP.PA trade?
Medesis Pharma S.A. (ALMDP.PA) trades on the Euronext Paris.
What sector is ALMDP.PA in?
Medesis Pharma S.A. (ALMDP.PA) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Medesis Pharma S.A.?
Jean-Claude Maurel MHB is the chief executive officer of Medesis Pharma S.A. (ALMDP.PA).
Where is Medesis Pharma S.A. headquartered?
Medesis Pharma S.A. is headquartered in France.
Does ALMDP.PA pay a dividend?
Medesis Pharma S.A. (ALMDP.PA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ALMDP.PA go public?
Medesis Pharma S.A. (ALMDP.PA) completed its initial public offering in 2021.